Skip to main content
. 2010 Feb 16;102(6):952–956. doi: 10.1038/sj.bjc.6605547

Table 3. Univariate and multivariate survival analysis.

  Disease-free survival
Overall survival
  Univariate analysisa
Multivariate analysisb
Univariate analysisa
Multivariate analysisb
  P-value HR (95% CI) P-value HR (95% CI) P-value HR (95% CI) P-value HR (95% CI)
Tumour stagec <0.001 <0.001 2.2 (1.7–2.8) <0.001 <0.001 2.1 (1.6–2.8)
Histological graded <0.001 0.04 1.4 (1.02–2.0) <0.001 0.002 1.8 (1.2–2.5)
Histological subtypee <0.001 0.1 1.7 (0.9–3.4) 0.002 0.6 1.3 (0.6–2.8)
Age <0.001 1.1 (1.0–1.1) 0.001 1.04 (1.02–1.1) <0.001 1.1 (1.0–1.1) <0.001 1.1 (1.03–1.1)
Plasma fibrinogen levelsf 0.002b 1.4 (1.1–1.8) 0.04 1.3 (1.01–1.6) 0.001 1.4 (1.1–1.8) 0.01 1.4 (1.1–1.2)

Abbreviation: HR (95% CI)=hazard ratio (95% confidence interval).

a

Kaplan–Meier analysis.

b

Multivariate Cox regression model.

c

FIGO I vs FIGO II vs FIGO III and IV.

d

G1 vs G2 vs G3.

e

Endometrioid vs non-endometrioid histology.

f

Plasma fibrinogen levels per 100 units.